A New Orleans woman died and two others were hospitalized after a lightning strike Friday night at a Larose outdoor music festival. According to Lafourche Parish Sheriff Craig Webre, Jackie Stavis, 28 ...
Keros Therapeutics (NASDAQ:KROS) stock plunged 73% Thursday after the company said it has halted two arms of a Phase 2 clinical study of its drug cibotercept in patients with pulmonary arterial ...
Hosted on MSN
Keros Stock Hits Rock Bottom After Pulmonary Hypertension Trial Halt, But Retail Bets On A Rebound
Keros Therapeutics Inc. shares lost over three-quarters of their market capitalization on Thursday, marking an all-time low, after the company halted two high-dose arms in its Phase 2 TROPOS trial of ...
Keros is a pre-revenue biotech with two therapies in phase 2 trials. The company focuses on treatments for blood and musculoskeletal disorders. Management says the company has enough cash to fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback